Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "evp of research development"

Shih Alvin, EVP of Research & Development of Retrophin (NASDAQ...

According to Retrophin's most recent Form 4 filing with the SEC dated Jun 02 09:04 PM, company EVP of Research & Development, Shih Alvin disclosed selling 8,750 shares at a cost of $17.75. At the time of this transaction (Jun 01), this trade was ... Empowered News, 3 weeks ago

Icon, Carnegie Mellon research validates shorter patient consent processes

Icon , a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and Carnegie Mellon University (CMU) partnered on patient consent process research. The results, which were ...
 Center Watch3 weeks ago ICON-Sponsored Research By Carnegie Mellon University Validates Shorter And Simpler Patient Consent Processes In Clinical Trials  BioSpace3 weeks ago

Aptuit Names Henning Steinhagen as EVP Drug Discovery and Development, and Site-Head Verona

GREENWICH, Connecticut, June 1, 2016 /PRNewswire/ Jonathan Goldman, CEO of Aptuit LLC, announced today the appointment of Henning Steinhagen, PhD, as Executive Vice President Drug Discovery and Development, and Site-Head Verona, completing Aptuit's ...
 PharmaVOICE3 weeks ago Aptuit Names EVP Drug Discovery and Development  Contract Pharma3 weeks ago
Bidness Etc

Kite Pharma Inc (KITE) Stock Gains on Research Partnership with Cell Design Labs

As per the partnership agreement, Kite will make an upfront payment to Cell Design Labs, along with additional compensation based on the achievement of various milestones Kite Pharma Inc. ( NASDAQ:KITE ) shares are on an upward trajectory today, ...
 Bidness Etc3 weeks ago BRIEF-Kite Pharma and Cell Design Inc collaborate on CAR-T immunotherapy research  Reuters UK3 weeks ago Kite Pharma and Cell Design Inc collaborate on CAR-T immunotherapy research  Pharma Focus Asia3 weeks ago Kite Pharma, Cell Design Labs Partner on...  Genetic Engineering News3 weeks ago

John Sweet Sells 12,000 Shares of Physicians Realty Trust (DOC) Stock

Physicians Realty Trust (NYSE:DOC) EVP John Sweet sold 12,000 shares of Physicians Realty Trust stock in a transaction that occurred on Tuesday, June 14th. The shares were sold at an average price of $19.90, for a total transaction of $238,800.00.
 American Banking News - Earnings2 weeks ago Insider Buying: Pinnacle Entertainment, Inc (PNK) EVP Acquires 15,000 Shares of Stock  American Banking News2 weeks ago The Medicines Company's (MDCO) Buy Rating Reaffirmed at Jefferies Group  American Banking News - Earnings2 weeks ago Vetr Inc. Upgrades Regeneron Pharmaceuticals Inc (REGN) to Strong-Buy  WKRB News2 weeks ago

REMINDER - What's Your People Story? PeopleMatter Webinar to Uncover Ways to Develop Successful Employer Brand

- WHO: PeopleMatter, a powerful and complete workforce management platform designed to fit the specific hiring, training, scheduling and performance management needs of service-industry brands, and Catch Talent, a recruiting and employer brand ...
 4 Traders2 weeks ago What's Your People Story? PeopleMatter Webinar to Uncover Ways to Develop Successful Employer Brand  4 Traders3 weeks ago

FLAVORS & FRAGRANCES : IFF Appoints Gregory Yep to EVP, Chief Global Scientific & Sustainability Officer

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF), a leading innovator of sensory experiences that move the world, has appointed Dr. Gregory Yep to the role of Executive Vice President, Chief Global Scientific ...
 4 Traders2 weeks ago IFF Appoints Gregory Yep to EVP  Citybizlist2 weeks ago IFF Appoints Gregory Yep to EVP, Chief Global Scientific & Sustainability Officer  Financial Buzz2 weeks ago

Atreca, Inc. Announces Election of Industry Leader David Lacey, M.D., to Its Board of Directors

REDWOOD CITY, Calif.--(Business Wire)--Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today the election of David Lacey, M.D., to the Company's ...
 Digital Journal3 weeks ago

Pfizer Inc. (NYSE:PFE) Given Consensus Rating of Buy by Brokerages

Shares of Pfizer Inc. (NYSE:PFE) have earned an average recommendation of Buy from the twenty-five research firms that are presently covering the firm. Eight research analysts have rated the stock with a hold rating, sixteen have issued a buy ...
 WKRB News2 weeks ago

American Superconductor Co. (AMSC) Earns Buy Rating from FBR & Co.

FBR & Co. reissued their buy rating on shares of American Superconductor Co. (NASDAQ:AMSC) in a research note released on Thursday morning. The firm currently has a $14.00 target price on the stock. A number of other analysts have also issued ...
 WKRB News3 weeks ago Brokerages Set SanDisk Co. (NASDAQ:SNDK) Price Target at $78.18  WKRB News3 weeks ago Advisor Partners LLC Increases Stake in Becton Dickinson and Co (BDX)  WKRB News2 weeks ago American Superconductor Co. (NASDAQ:AMSC) Receives Consensus Recommendation of Buy from Analysts  American Banking News - Earnings2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less